We work with whistleblowers to expose fraud against the government.

Education & Research Fraud

Qui tam claims protect deserving recipients of grants and loans.

Government grants and loans are essential to the pursuit of groundbreaking research efforts and individual educational endeavors — and the government needs and wants to know when fraudulent actions are diverting funds from deserving recipients. Persons who are aware of fraudulent grant claims may be eligible to collect a reward from the government if they are able to successfully bring about a qui tam whistleblower lawsuit against the parties responsible.

Every year, the Department of Education makes billions of treasury dollars available to institutions to help students pay for higher education at public, private nonprofit, and private for-profit schools. To qualify for these funds, however, students and schools must both satisfy certain eligibility requirements. Cases of student loan fraud often involve institutions of higher learning making false statements to the Department of Education in order to meet these requirements.

The False Claims Act has been used to recover millions of tax dollars from educational programs and institutions that use fraudulent marketing practices or deceptive recruitment tactics, improperly and aggressively recruit unqualified students, misrepresent compliance and student data to the Department of Education, and improperly retain unqualified students in order to continue requesting loans. Recently, a number of for-profit colleges, including the University of Phoenix and Kaplan, have been pursued for enrolling and therefore, enabling, otherwise ineligible students to qualify for federal student loans.

Universities, nonprofit organizations, and hospitals often depend on government-issued grants to conduct important research for the common good on a wide variety of topics. Unfortunately, grant recipients sometimes misuse these funds.

Familiar areas of grant funding involve research at academic medical centers, hospitals, and other institutions. At academic medical centers, for example, federal payments for research overhead, called indirect payments, total tens of millions of dollars a year. Inflated costs often violate the provisions of the federal grant applications that the government approved. In a recent qui tam case, the National Institutes of Health (NIH) provided Cornell’s Weill Medical College a five-year, $23 million grant to study a variety of children’s diseases. The federal government learned of fraud through a whistleblower and filed a lawsuit against Cornell claiming that the university had been awarded federal funding for research that never happened. Additionally, Cornell billed NIH for nurses who were supposed to focus exclusively on pediatric research yet were routinely at work treating regular patients, and falsified the grant application by including the salaries of phantom nurses to inflate its research costs. The university ultimately paid a $4.4 million settlement to the government.

  • Paying for inflated overhead expenses, such as salaries or expenses for another project or other work
  • Overstating expenses and misdirecting money
  • Making false grant claims or misrepresentations on grant applications
  • Failing to fully disclose funding sources
  • Making false statements in the administration of grant money
  • Overstating success to receive additional payments

What is Qui Tam?

Under the Federal False Claims Act (FCA), whistleblowers have the power to save taxpayers billions of dollars each year by taking a stand against fraud. The U.S. False Claims Act allows private citizens to file suits on the government’s behalf when the government has been defrauded through any federally funded contract or program. The qui tam provisions of the False Claims Act allow these citizens to recover damages. A number of states and the city of Chicago also have laws similar to the False Claims Act to protect against fraud. To learn more about the different types of fraud … READ MORE

WKPS Whistleblower Client Assists in $13.6M FCA Healthcare Billing Fraud Recovery

February 13, 2026 The U.S. Department of Justice has reached a $13.6 million healthcare billing fraud settlement with an Austin-based pain management medical practice in a case that began with a Waters Kraus Paul & Siegel whistleblower client. According to the settlement announced...

WKPS Client Helps Secure $18.2M FCA Fraud Settlement with CVS

December 9, 2025 CVS Pharmacy has agreed to pay $18.2 million to the United States and the State of California to resolve allegations that the company violated the federal and California False Claims Acts by submitting unsupported reimbursement claims to the Medi-Cal program....

Our Results

$880 million award

Historic settlement for over 1,300 survivors of clergy and adult abuse within the Roman Catholic Archdiocese of Los Angeles, marking a pivotal moment for justice.

READ THE DETAILS

$725.5 million award

A Philadelphia jury awarded a record verdict against ExxonMobil for failing to warn about cancer risks due to benzene in its petroleum products.

READ THE DETAILS

$25 million award

Private equity firm and co-defendants agree to pay $25M in Medicaid fraud case alleging mental health services provided by unqualified providers.

READ THE DETAILS